Replies to post #154619 on Biotech Values

[ronpopeil]

Thanks. I think AEGR got approval on a surrogate endpoint. Should bode well for them with the EMEA

[DewDiligence]

FDA, EMA disagree on drug approvals 22% of the time, according to Reuters:

http://www.reuters.com/article/2015/03/18/us-pharmaceuticals-regulations-sanofi-idUSKBN0ME26E20150318

22% sounds a little high, IMO.